PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
09-Feb-2021 Ipsen and Mendelian Announce Landmark Partnership to Reshape Rare Disease Diagnosis using Pioneering MendelScan Technology Ipsen
09-Feb-2021 Scottish Medicines Consortium accepts PROSTAP® SR DCS & PROSTAP® 3 DCS (leuprorelin acetate) to treat early and advanced breast cancer Takeda
09-Feb-2021 ViiV Healthcare receives Marketing Authorisation for Rukobia (fostemsavir), a first-in-class attachment inhibitor in combination with other antiretrovirals for the treatment of adults with multidrug-resistant HIV ViiV Healthcare
09-Feb-2021 Nass Valley Gateway Ltd. Announces It Will Add CBD Veteran Jeanine Getz to Its Board of Directors Nass Valley Gateway Ltd.
09-Feb-2021 UCL becomes first global academic institution to offer comprehensive Masters of Surgery (MS) in Aesthetics and Minimally-Invasive Aesthetics UCL
09-Feb-2021 G&L Scientific expandiert nach Deutschland Sciad Newswire
09-Feb-2021 La G&L Scientific approda in Italia Sciad Newswire
09-Feb-2021 G&L Scientific étend sa présence en France Sciad Newswire
09-Feb-2021 Antibiotic Research UK calls for clear guidance to ensure people on antibiotics do not miss out on the COVID-19 vaccine Sciad Newswire
09-Feb-2021 Evotec and Related Sciences enter integrated drug discovery and development partnership Evotec SE
09-Feb-2021 Relief Announces Resignation of Thomaz Burckhardt as Member of the Board of Directors RELIEF THERAPEUTICS Holdings AG
08-Feb-2021 ViiV Healthcare receives Marketing Authorisation for Rukobia (fostemsavir), a first-in-class attachment inhibitor in combination with other antiretrovirals for the treatment of adults with multidrug-resistant HIV ViiV Healthcare
08-Feb-2021 FDA grants Breakthrough Device Designation for Roche's Elecsys Growth Differentiation Factor-15 (GDF-15) assay to help identify patients suitable for innovative treatment addressing unintentional weight loss in cancer patients Roche
08-Feb-2021 MagForce AG: MagForce USA, Inc. Announces Completion of Patient Treatment in Stage 2a of Pivotal U.S. Single-Arm Study for the Focal Ablation of Intermediate Risk Prostate Cancer with the NanoTherm Therapy System MagForce AG
08-Feb-2021 MagForce AG: MagForce USA, Inc. Announces Completion of Patient Treatment in Stage 2a of Pivotal U.S. Single-Arm Study for the Focal Ablation of Intermediate Risk Prostate Cancer with the NanoTherm Therapy System MagForce AG
08-Feb-2021 Eckert & Ziegler Wins Order for Hot Cell Construction from Dutch Research Center Eckert & Ziegler Strahlen- und Medizintechnik AG
08-Feb-2021 Relief Affirms Initiation of Phase 2/3 Trial of Inhaled RLF-100(TM) (Aviptadil; ZYESAMI(TM)) in Severe COVID-19 Patients RELIEF THERAPEUTICS Holdings AG
05-Feb-2021 Lilly Announces Webcast to Provide Alzheimer's Disease Update at AD/PD Conference Eli Lilly
05-Feb-2021 Gilead Joins OneTen Coalition Aimed at Creating 1 Million Jobs for Black Americans Gilead
05-Feb-2021 PureTech Founded Entity Vor Biopharma Announces Pricing of Initial Public Offering PureTech